Further, in vitro research has revealed that EVOO PPs can induce arrest of the cell cycle at the G2/M phase, inhibit proteins that prevent apoptosis, and reduce the expression of HER2, an oncogene commonly overexpressed in aggressive breast cancer subtypes [151]. This evidence concerns the gene ERBB2 and breast carcinoma.